Literature DB >> 30191443

Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions.

Ulla Feldt-Rasmussen1, Marianne Klose2, Salvatore Benvenga3,4,5.   

Abstract

Central hypothyroidism is defined as low circulating free thyroxine (free T4) with inappropriately low circulating thyrotropin (TSH), in context of a hypothalamic pituitary pathology. Rare cases of idiopathic central hypothyroidism caused by a functional defect may occur, and the condition is often overlooked due to difficulty in achieving the correct diagnosis, sparse symptomatology of the condition and a high risk of misinterpretion of the biochemical changes in central hypothyroidism. Central hypothyroidism is mainly seen in patients with hypothalamic-pituitary pathology due to one of many possible aetiologies, where other hormone deficiencies often co-exist, and both the presence of other deficiencies and their replacement have a strong influence on the measurement of the thyroid-related hormones and thereby interpretation of the thyroid function variables in relation to the clinical impact of thyroid hormone substitution therapy. Conversely, lack of thyroid hormone has a similar strong influence on the interpretation of other pituitary hormone axes, as well as their replacement. Undertreating patients with central hypothyroidism may have serious metabolic consequences with a potentially increased risk of cardiovascular morbidity. The present review thus aims at describing central hypothyroidism, by an overview of interactions of hypothyroidism with other pituitary hormones, diagnosing/testing for central hypothyroidism, and focusing on consequences of undertreatment. Finally, it is mentioned how to deal with new diagnostic settings with lower a priori likelihood of hypopituitarism, particularly in view of the importance of stringent diagnostic testing in order to avoid overdiagnosing central hypothyroidism.

Entities:  

Keywords:  Central hypothyroidism; Diagnosis; Hypopituitarism; Pituitary testing; Thyrotropin deficiency

Mesh:

Substances:

Year:  2018        PMID: 30191443     DOI: 10.1007/s12020-018-1738-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  69 in total

1.  Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity.

Authors:  J H Oliveira; L Persani; P Beck-Peccoz; J Abucham
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

2.  The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

Authors:  Helena Filipsson Nyström; Ulla Feldt-Rasmussen; Ione Kourides; Vera Popovic; Maria Koltowska-Häggström; Björn Jonsson; Gudmundur Johannsson
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

3.  Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease.

Authors:  Stig Andersen; Klaus Michael Pedersen; Niels Henrik Bruun; Peter Laurberg
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

Review 4.  Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients.

Authors:  Ulla Feldt-Rasmussen; Marianne Klose
Journal:  Endocrine       Date:  2016-08-01       Impact factor: 3.633

5.  Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation.

Authors:  A Lando; K Holm; K Nysom; U Feldt-Rasmussen; J H Petersen; J Müller
Journal:  Clin Endocrinol (Oxf)       Date:  2001-07       Impact factor: 3.478

Review 6.  Central hypothyroidism - a neglected thyroid disorder.

Authors:  Paolo Beck-Peccoz; Giulia Rodari; Claudia Giavoli; Andrea Lania
Journal:  Nat Rev Endocrinol       Date:  2017-05-26       Impact factor: 43.330

7.  The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis.

Authors:  Ane Garmendia Madariaga; Silvia Santos Palacios; Francisco Guillén-Grima; Juan C Galofré
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

8.  Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults.

Authors:  J O Jørgensen; J Møller; T Laursen; H Orskov; J S Christiansen; J Weeke
Journal:  Clin Endocrinol (Oxf)       Date:  1994-11       Impact factor: 3.478

9.  Should Free Thyroxine Go Back into the Routine Thyroid Profile?

Authors:  M Livingston; P J Twomey; A Basu; S Smellie; J W Kane; A Heald
Journal:  Exp Clin Endocrinol Diabetes       Date:  2015-11-24       Impact factor: 2.949

Review 10.  Thyroid testing in acutely ill patients may be an expensive distraction.

Authors:  Lakdasa D Premawardhana
Journal:  Biochem Med (Zagreb)       Date:  2017-06-15       Impact factor: 2.313

View more
  3 in total

Review 1.  L-T4 Therapy in the Presence of Pharmacological Interferents.

Authors:  Salvatore Benvenga
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-22       Impact factor: 5.555

2.  Prediction models constructed for Hashimoto's thyroiditis risk based on clinical and laboratory factors.

Authors:  Peng Li; Fang Liu; Minsu Zhao; Shaokai Xu; Ping Li; Jingang Cao; Dongming Tian; Yaopeng Tan; Lina Zheng; Xia Cao; Yingxia Pan; Hui Tang; Yuanyuan Wu; Yi Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

Review 3.  The diagnosis and management of central hypothyroidism in 2018.

Authors:  Luca Persani; Biagio Cangiano; Marco Bonomi
Journal:  Endocr Connect       Date:  2019-02       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.